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ABSTRACT 
The Melastomataceae is a large family of flowering plants consisting of trees, shrubs as 
well as epiphytes and are found throughout the tropics including Malaysia. However, 
only a handful of species have been studied for their phytochemical properties including 
the ones found in Malaysia. The present study was undertaken to evaluate the cytotoxic 
activities of the crude methanol (CME), ethyl acetate (CEE) and hexane extracts (CHE) 
of four selected wild species namely Melastoma muticum, Melastoma sanguineum, 
Memecylon caeruleum and Phyllagathis rotundifolia. Extracts of these species were 
prepared from the leaves and cytotoxic activities were screened by an in vitro assay 
system of growth inhibition against human breast MCF-7 cancer cell lines and human 
ovarian SKOV-3 cancer cell lines. CEE of P. rotundifolia exhibited the most potent 
cytotoxicity on MCF-7 cell lines (IC50 = 0.92 ± 0.01 µg/ml, SI = 8.22), while CEE of  
M. caeruleum possessed high cytotoxicity on SKOV-3 cell lines (IC50 = 16.04 ± 1.68 
µg/ml, SI = 3.26). Qualitative phytochemical studies of the CME of the selected species 
revealed the presence of phenols, flavonoids, and tannins. Identification of the major 
compounds in CEE of P. rotundifolia and M. caeruleum were done by using              
LC-MS/MS system and phenolic groups were detected as the major compounds in both 
extracts. Total Phenolic Content (TPC) assay was done to measure the phenolic contents 
of each extract and CME of M. sanguineum exhibited the highest phenolic contents 
(718.18 ± 8.91 mg GAE/100 g). Antioxidant properties were studied by Ferric Reducing 
Antioxidant Power (FRAP) and 2,2-diphenyl-1-picrylhydrazyl (DPPH) assays and CME 
of M. sanguineum was found to show the highest reducing activities (68.89 ± 0.50 
µM/100 g) while CME of M. muticum exhibited the high free radical scavenging 
activities (IC50 = 77.1 ± 2.8 µg/ml).  
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ABSTRAK 
Melastomataceae ialah famili tumbuhan berbunga yang besar terdiri daripada pepohon, 
tumbuhan renek, dan juga epifit dijumpai di kawasan tropik termasuk Malaysia. Walau 
bagaimanapun, hanya segelintir spesis sahaja yang dikaji untuk kandungan serta aktiviti 
fitokimia, termasuk spesis yang dijumpai di Malaysia. Kajian ini dijalankan untuk 
mengkaji aktiviti sitotoksik ekstrak metanol (CME), etil asetat (CEE), and heksana 
(CHE) daripada empat spesis terdiri daripada Melastoma muticum, Melastoma 
sanguineum, Memecylon caeruleum, dan Phyllagathis rotundifolia. Ekstrak daun 
daripada spesis disediakan dan aktiviti sitotoksik di uji menggunakan assai ‘in vitro’ 
dengan sistem halangan pertumbuhan sel MCF-7 kanser payudara manusia dan sel 
SKOV-3 kanser ovari manusia. CEE daripada P. rotundifolia menunjukkan aktiviti 
sitotoksik paling tinggi terhadap sel MCF-7 (IC50 = 0.92 ± 0.01 µg/ml, SI = 8.22) 
manakala, CEE daripada M. caeruleum pula mempunyai aktiviti sitotoksik terhadap sel 
SKOV-3 (IC50 = 16.04 ± 1.68 µg/ml, SI = 3.26). Kajian fitokimia secara kualitatif ke 
atas CME spesis terpilih menunjukkan kehadiran fenol, flavonoid, dan tanin. 
Pengenalpastian sebatian utama di dalam CEE P. rotundifolia dan M. caeruleum 
dilakukan menggunakan sistem LC-MS/MS dan didapati kumpulan fenolik adalah 
bahan utama yang dikesan di dalam kedua-dua ekstrak. Kandungan fenolik setiap 
ekstrak di ukur dengan menggunakan assai ‘Total Phenolic Content’ (TPC) dan CME 
daripada M. sanguineum menunjukkan kandungan fenolik tertinggi (718.18 ± 8.91 mg 
GAE/100 g). Potensi antioksidan menggunakan ‘Ferric Reducing Antioxidant Power’ 
(FRAP) dan ‘2,2-diphenyl-1-picrylhydrazyl’ (DPPH) telah dikaji dan ekstrak CME 
daripada M. sanguineum menunjukkan aktiviti pengurangan oksida tertinggi (68.89 ± 
0.50 µM/100 g) sementara itu CME daripada M. muticum pula mempamerkan aktiviti 
pengaut radikal bebas tinggi (IC50 = 77.1 ± 2.8 µg/ml). 
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